NASDAQ:VCYT
Veracyte, Inc.
Veracyte, Inc.'s revenue grew 16.0% in fiscal 2025 to $517.1M while operating margin rose to 11.2%, its highest in 10 years. Free cash flow was $126.6M, 24.5% of revenue, and the diluted share count rose 3.1%.Summary generated from Veracyte, Inc.'s SEC filings. Latest annual report filed Feb 26, 2026.
Key statistics
Fiscal 2025 from SEC filings. MethodologyRevenue (FY25)$517.1M
Revenue growth+16.0%
Revenue, 5-yr CAGR+34.5%
Gross margin70.1%
Operating margin11.2%
Net margin12.8%
ROICn/a
Return on equity5.3%
Debt / equityn/a
Free cash flow$126.6M
FCF margin24.5%
Share count change+3.1%
Financials
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 220 | 297 | 361 | 446 | 517 |
| Operating income | −82 | −41 | −86 | 16 | 58 |
| Net income | −76 | −37 | −74 | 24 | 66 |
| Free cash flow | −37 | −1 | 34 | 64 | 127 |
Recent filings
- 4Insider transaction report
Sep 22, 2026 - 4Insider transaction report
Sep 16, 2026 - 8-KEntry into a material agreement
Sep 14, 2026 - 10-QQuarterly report for the period ended Jun 30, 2026
Jul 31, 2026 - 8-KResults of operations and financial condition
Jul 30, 2026 - 8-KDirector or officer change
Jun 11, 2026 - 10-QQuarterly report for the period ended Mar 31, 2026
May 6, 2026 - 8-KResults of operations and financial condition
May 5, 2026